vs

Side-by-side financial comparison of Bilibili Inc. (BILI) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× Bilibili Inc.). Bilibili Inc. runs the higher net margin — 6.0% vs 0.1%, a 5.9% gap on every dollar of revenue. On growth, Bilibili Inc. posted the faster year-over-year revenue change (26.2% vs 14.5%). Over the past eight quarters, Bilibili Inc.'s revenue compounded faster (27.3% CAGR vs 10.8%).

Bilibili, nicknamed B Site, is a Chinese online video sharing website based in Shanghai where users can submit, view, and add overlaid commentary on videos.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

BILI vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.5× larger
CME
$1.9B
$1.3B
BILI
Growing faster (revenue YoY)
BILI
BILI
+11.7% gap
BILI
26.2%
14.5%
CME
Higher net margin
BILI
BILI
5.9% more per $
BILI
6.0%
0.1%
CME
Faster 2-yr revenue CAGR
BILI
BILI
Annualised
BILI
27.3%
10.8%
CME

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BILI
BILI
CME
CME
Revenue
$1.3B
$1.9B
Net Profit
$75.7M
$1.2M
Gross Margin
37.0%
Operating Margin
5.8%
0.1%
Net Margin
6.0%
0.1%
Revenue YoY
26.2%
14.5%
Net Profit YoY
143.0%
20.7%
EPS (diluted)
$1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BILI
BILI
CME
CME
Q1 26
$1.9B
Q4 25
$1.3B
$1.6B
Q3 25
$1.1B
$1.5B
Q2 25
$1.0B
$1.7B
Q1 25
$965.1M
$1.6B
Q4 24
$1.0B
$1.5B
Q3 24
$1.0B
$1.6B
Q2 24
$843.1M
$1.5B
Net Profit
BILI
BILI
CME
CME
Q1 26
$1.2M
Q4 25
$75.7M
$1.2B
Q3 25
$65.9M
$908.0M
Q2 25
$30.5M
$1.0B
Q1 25
$-1.5M
$956.2M
Q4 24
$-176.0M
$874.6M
Q3 24
$11.4M
$912.8M
Q2 24
$83.7M
$883.2M
Gross Margin
BILI
BILI
CME
CME
Q1 26
Q4 25
37.0%
Q3 25
36.7%
Q2 25
36.5%
Q1 25
36.3%
Q4 24
36.2%
Q3 24
34.9%
Q2 24
29.9%
Operating Margin
BILI
BILI
CME
CME
Q1 26
0.1%
Q4 25
5.8%
61.8%
Q3 25
4.6%
63.3%
Q2 25
3.4%
66.7%
Q1 25
0.2%
67.5%
Q4 24
-16.0%
62.1%
Q3 24
0.9%
64.6%
Q2 24
9.5%
65.3%
Net Margin
BILI
BILI
CME
CME
Q1 26
0.1%
Q4 25
6.0%
71.7%
Q3 25
6.1%
59.1%
Q2 25
3.0%
60.6%
Q1 25
-0.2%
58.2%
Q4 24
-17.5%
57.3%
Q3 24
1.1%
57.6%
Q2 24
9.9%
57.6%
EPS (diluted)
BILI
BILI
CME
CME
Q1 26
Q4 25
$1.14
$3.24
Q3 25
$1.05
$2.49
Q2 25
$0.51
$2.81
Q1 25
$0.00
$2.62
Q4 24
$0.21
$2.40
Q3 24
$-0.03
$2.50
Q2 24
$-0.20
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BILI
BILI
CME
CME
Cash + ST InvestmentsLiquidity on hand
$2.7B
$2.4B
Total DebtLower is stronger
$1.4B
$3.4B
Stockholders' EquityBook value
$2.2B
Total Assets
$5.9B
$202.0B
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BILI
BILI
CME
CME
Q1 26
$2.4B
Q4 25
$2.7B
$4.5B
Q3 25
$2.4B
$2.6B
Q2 25
$2.1B
Q1 25
$1.9B
$1.5B
Q4 24
$1.8B
$3.0B
Q3 24
$11.7B
$2.4B
Q2 24
$1.9B
Total Debt
BILI
BILI
CME
CME
Q1 26
$3.4B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
Q1 25
$700.3M
Q4 24
$662.5M
Q3 24
$4.3B
Q2 24
Stockholders' Equity
BILI
BILI
CME
CME
Q1 26
Q4 25
$2.2B
$28.7B
Q3 25
$2.1B
$28.2B
Q2 25
$27.7B
Q1 25
$2.0B
$27.0B
Q4 24
$1.9B
$26.5B
Q3 24
$13.7B
$28.2B
Q2 24
$27.6B
Total Assets
BILI
BILI
CME
CME
Q1 26
$202.0B
Q4 25
$5.9B
$198.4B
Q3 25
$5.6B
$187.1B
Q2 25
$179.9B
Q1 25
$4.6B
$157.8B
Q4 24
$4.5B
$137.4B
Q3 24
$32.0B
$137.8B
Q2 24
$123.4B
Debt / Equity
BILI
BILI
CME
CME
Q1 26
Q4 25
0.62×
Q3 25
0.65×
Q2 25
Q1 25
0.35×
Q4 24
0.34×
Q3 24
0.31×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BILI
BILI
CME
CME
Operating Cash FlowLast quarter
$263.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BILI
BILI
CME
CME
Q1 26
Q4 25
$263.1M
$1.1B
Q3 25
$283.2M
$968.1M
Q2 25
$277.7M
$1.1B
Q1 25
$179.4M
$1.1B
Q4 24
$191.9M
$1.0B
Q3 24
$2.2B
$1.0B
Q2 24
$776.9M
Free Cash Flow
BILI
BILI
CME
CME
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$174.5M
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
BILI
BILI
CME
CME
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
18.1%
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
BILI
BILI
CME
CME
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.5%
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
BILI
BILI
CME
CME
Q1 26
Q4 25
3.47×
0.96×
Q3 25
4.30×
1.07×
Q2 25
9.11×
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
195.23×
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BILI
BILI

Value-added services (VAS)$466.4M37%
Advertising$435.0M34%
Mobile games$220.3M17%
Other$80.8M6%
IP derivatives and others$68.2M5%

CME
CME

Segment breakdown not available.

Related Comparisons